In pancreatic cancer, KDM4B has been shown to regulate ZEB1 expression during TGF-β -induced EMT, and silencing KDM4B can significantly inhibit the migration and invasion of pancreatic cancer cells and EMT (Li et al., 2015). Here, KDM4B is linked to familial pancreatic carcinoma.